CVS is obviously a toss. Let's hope that others are doing much better and we are beginning to get some milestone payments from P&G.
Let's save BPI for later. That should be huge and is one that only success is the acceptable outcome. We would rather BPI plans and executes perfectly, than it comes to market hastily and oops... That would be disastrous.
Going into the future, we should look forward to the company's non-supplement, high volume ingredients business gaining traction. The co. is in talk with a few Fortune 500 cos. on these. Realistically, that might be a 2017 story. But Jaksch should keep on talking about it.
Market Data 
Markets 
AI
